North Star Assessment for limb-girdle type muscular dystrophies (NSAD)

North Star Assessment for limb-girdle type muscular dystrophies (NSAD)

Price: $ 25.00

4.8(496)

Download scientific diagram | North Star Assessment for limb-girdle type muscular dystrophies (NSAD) person-item threshold distribution plot demonstrating good coverage of items for the population. The top histogram illustrates the abilities of the population, from the weakest on the left to the strongest on the right. The bottom histogram demonstrates a well-distributed range of items that test the ability of the population, with a ceiling for the individuals who were the very strongest and asymptomatic. from publication: Validation of the North Star Assessment for Limb-Girdle Type Muscular Dystrophies | Objective. The North Star Assessment for limb-girdle type muscular dystrophies (NSAD), a clinician-reported outcome measure (ClinRO) of motor performance, was initially developed and validated for use in dysferlinopathy, an autosomal recessive form of limb-girdle muscular | Muscular Dystrophy, Limb-Girdle Muscular Dystrophies and Neuromuscular Diseases | ResearchGate, the professional network for scientists.

https://www.parentprojectmd.org/wp-content/uploads/2022/04/edgewise-2022.png

Edgewise Announces Positive 2-Month Interim Results from Open Label Study of EDG-5506 in Adults with Becker - Parent Project Muscular Dystrophy

https://d3i71xaburhd42.cloudfront.net/bbd77374e67e45ec725cab00b469d3e23c46972f/7-Figure2-1.png

PDF] Assessment of disease progression in dysferlinopathy

https://media.zenfs.com/en/globenewswire.com/348c5f181c792be0d154f6e91c700d1a

BridgeBio Pharma Shares Positive Long-Term Data from an Ongoing Phase 2 Study, which Support the Potential Use of Glycosylated Alpha-dystroglycan (⍺DG) Levels as a Surrogate Endpoint in Limb-girdle Muscular Dystrophy Type 2I/R9 (

https://www.genebase.com/wp-content/uploads/sites/17/limb2E_3.jpg

Limb-Girdle Muscular Dystrophy Type 2E - Genebase

https://onlinelibrary.wiley.com/cms/asset/37820184-7beb-4128-840d-0167b7cbccc0/ana26044-fig-0003-m.jpg

Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale - Jacobs - 2021 - Annals of Neurology - Wiley Online Library

https://onlinelibrary.wiley.com/cms/asset/338fadb7-6a7c-4253-9ceb-7ebe36646876/ana26044-fig-0001-m.jpg

Assessing Dysferlinopathy Patients Over Three Years With a New Motor Scale - Jacobs - 2021 - Annals of Neurology - Wiley Online Library

https://www.researchgate.net/publication/349288982/figure/fig2/AS:1025073532137473@1621407983411/Functional-outcome-trajectories-during-the-study-period-by-patient-characteristic-Fitted.ppm

Functional outcome trajectories during the study period by patient

https://media.springernature.com/lw685/springer-static/image/chp%3A10.1007%2F978-3-031-07465-3_2/MediaObjects/482586_1_En_2_Fig5_HTML.png

A Clinician's Guide to Performance Outcome Measurements

https://ars.els-cdn.com/content/image/1-s2.0-S0960896621000109-gr3.jpg

Miyoshi myopathy and limb girdle muscular dystrophy R2 are the same disease - ScienceDirect

https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=1987345838097209

Muscular Dystrophy Association Singapore - Today is Limb-Girdle Muscular Dystrophy (LGMD) Awareness Day! Limb-girdle muscular dystrophies (LGMD) are a rare group of progressive genetic illnesses that usually affects the proximal muscles around